Skip to Main Content
DownloadHi-Res Photo

Inci Yildirim

MD, PhD, MSc
Associate Professor of Pediatrics (Infectious Disease) and of Public Health (Epidemiology of Microbial Diseases); Medical Director, Transplant Infectious Diseases; Affiliated Faculty, Yale Institute for Global Health

Contact Information

Inci Yildirim, MD, PhD, MSc

Mailing Address

  • Pediatric Infectious Diseases

    Child Health Research Center, 464 Congress Avenue

    NEW HAVEN, United States 06529

    United States

Yale Medicine

Patient Care

Are you a patient?Please visit the Yale Medicine website for information about the services we offer and making an appointment.View Doctor Profile

Research Summary

Dr. Yildirim has current research in the following areas:

  1. Yale SCD Cohort
  2. Study to Evaluate Safety and Effectiveness of mRNA -1273 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age
  3. Vaccines in Immunocompromised
  4. A Phase 3 Trial to Evaluate the Clinical Efficacy and Safety of RSV preF in Infants Born to Vaccinated Pregnant Women
  5. Corporate Mix for Healthcare Workers
  6. Exemption: AFIX -OB Aim 2
  7. Corporate Mix
  8. MVAC PAHO
  9. RSV Mortality Study: Formative Phase
  10. RSV Mortality Study in Pakistan: Surveillance Phase
  11. GBS study in Pakistan
  12. IMPACT Biorepository

Coauthors

Public Health Interests

Clinical Trials; Epidemiology Methods; Infectious Diseases; Vaccines; Child/Adolescent Health; COVID-19

Selected Publications

  • Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age.Creech CB, Anderson E, Berthaud V, Yildirim I, Atz AM, Melendez Baez I, Finkelstein D, Pickrell P, Kirstein J, Yut C, Blair R, Clifford RA, Dunn M, Campbell JD, Montefiori DC, Tomassini JE, Zhao X, Deng W, Zhou H, Ramirez Schrempp D, Hautzinger K, Girard B, Slobod K, McPhee R, Pajon R, Das R, Miller JM, Schnyder Ghamloush S. Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age. The New England Journal Of Medicine 2022, 386: 2011-2023. PMID: 35544369, DOI: 10.1056/NEJMoa2203315.
  • Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity.Lucas C, Vogels CBF, Yildirim I, Rothman JE, Lu P, Monteiro V, Gehlhausen JR, Campbell M, Silva J, Tabachnikova A, Peña-Hernandez MA, Muenker MC, Breban MI, Fauver JR, Mohanty S, Huang J, Shaw AC, Ko AI, Omer SB, Grubaugh ND, Iwasaki A. Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity. Nature 2021, 600: 523-529. PMID: 34634791, DOI: 10.1038/s41586-021-04085-y.
  • Bloodstream Infections in Children With Sickle Cell Disease: 2010-2019.Yee ME, Lai KW, Bakshi N, Grossman JK, Jaggi P, Mallis A, Wang YF, Jerris RC, Lane PA, Yildirim I. Bloodstream Infections in Children With Sickle Cell Disease: 2010-2019. Pediatrics 2022, 149 PMID: 34913059, PMCID: PMC8959248, DOI: 10.1542/peds.2021-051892.
  • A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Hospitalizations in Children.Yildirim I, Kao CM, Tippett A, Suntarattiwong P, Munye M, Yi J, Elmontser M, Quincer E, Focht C, Watson N, Bilen H, Baker JM, Lopman B, Hogenesch E, Rostad CA, Anderson EJ. A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Hospitalizations in Children. Clinical Infectious Diseases : An Official Publication Of The Infectious Diseases Society Of America 2021, 73: 1759-1767. PMID: 34410341, PMCID: PMC8599178, DOI: 10.1093/cid/ciab709.
  • Delayed production of neutralizing antibodies correlates with fatal COVID-19.Lucas C, Klein J, Sundaram ME, Liu F, Wong P, Silva J, Mao T, Oh JE, Mohanty S, Huang J, Tokuyama M, Lu P, Venkataraman A, Park A, Israelow B, Vogels CBF, Muenker MC, Chang CH, Casanovas-Massana A, Moore AJ, Zell J, Fournier JB, Wyllie AL, Campbell M, Lee A, Chun HJ, Grubaugh ND, Schulz WL, Farhadian S, Dela Cruz C, Ring AM, Shaw AC, Wisnewski AV, Yildirim I, Ko AI, Omer S, Iwasaki A. Delayed production of neutralizing antibodies correlates with fatal COVID-19. Nature Medicine 2021, 27: 1178-1186. PMID: 33953384, PMCID: PMC8785364, DOI: 10.1038/s41591-021-01355-0.
  • Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.Doria-Rose N, Suthar MS, Makowski M, O'Connell S, McDermott AB, Flach B, Ledgerwood JE, Mascola JR, Graham BS, Lin BC, O'Dell S, Schmidt SD, Widge AT, Edara VV, Anderson EJ, Lai L, Floyd K, Rouphael NG, Zarnitsyna V, Roberts PC, Makhene M, Buchanan W, Luke CJ, Beigel JH, Jackson LA, Neuzil KM, Bennett H, Leav B, Albert J, Kunwar P, mRNA-1273 Study Group.. Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19. N Engl J Med 2021.
  • The burden of respiratory syncytial virus infections among children with sickle cell disease.Rostad CA, Maillis AN, Lai K, Bakshi N, Jerris RC, Lane PA, Yee ME, Yildirim I. The burden of respiratory syncytial virus infections among children with sickle cell disease. Pediatric Blood & Cancer 2021, 68: e28759. PMID: 33034160, PMCID: PMC8246443, DOI: 10.1002/pbc.28759.
  • Vaccine-induced protection against hepatitis B in pediatric solid organ transplant patients.Ball M, Liverman R, Serluco A, Yildirim I. Vaccine-induced protection against hepatitis B in pediatric solid organ transplant patients. Pediatric Transplantation 2021, 25: e13920. PMID: 33217081, DOI: 10.1111/petr.13920.
  • Risk of Disseminated Gonococcal Infections With Terminal Complement Blockade.Graciaa SH, Graciaa DS, Yildirim I, Chonat S. Risk of Disseminated Gonococcal Infections With Terminal Complement Blockade. Journal Of Pediatric Hematology/oncology 2022, 44: e493-e495. PMID: 33560079, PMCID: PMC8556643, DOI: 10.1097/MPH.0000000000002075.
  • Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project.Bennett JC, Hetrich MK, Garcia Quesada M, Sinkevitch JN, Deloria Knoll M, Feikin DR, Zeger SL, Kagucia EW, Cohen AL, Ampofo K, Brandileone MC, Bruden D, Camilli R, Castilla J, Chan G, Cook H, Cornick JE, Dagan R, Dalby T, Danis K, de Miguel S, De Wals P, Desmet S, Georgakopoulou T, Gilkison C, Grgic-Vitek M, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kellner JD, Kleynhans J, Knol MJ, Kozakova J, Kristinsson KG, Ladhani SN, MacDonald L, Mackenzie GA, Mad'arová L, McGeer A, Mereckiene J, Morfeldt E, Mungun T, Muñoz-Almagro C, Nuorti JP, Paragi M, Pilishvili T, Puentes R, Saha SK, Sahu Khan A, Savrasova L, Scott JA, Skoczyńska A, Suga S, van der Linden M, Verani JR, von Gottberg A, Winje BA, Yildirim I, Zerouali K, Hayford K. Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project. Microorganisms 2021, 9 PMID: 33801760, PMCID: PMC8066231, DOI: 10.3390/microorganisms9040696.
  • Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.Widge AT, Rouphael NG, Jackson LA, Anderson EJ, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott AB, Flach B, Lin BC, Doria-Rose NA, O'Dell S, Schmidt SD, Neuzil KM, Bennett H, Leav B, Makowski M, Albert J, Cross K, Edara VV, Floyd K, Suthar MS, Buchanan W, Luke CJ, Ledgerwood JE, Mascola JR, Graham BS, Beigel JH, mRNA-1273 Study Group.. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. N Engl J Med 2020.
  • An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O'Dell S, Schmidt SD, Swanson PA 2nd, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JH, mRNA-1273 Study Group.. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. N Engl J Med 2020.
  • Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott AB, Flach B, Lin BC, Doria-Rose NA, O'Dell S, Schmidt SD, Corbett KS, Swanson PA 2nd, Padilla M, Neuzil KM, Bennett H, Leav B, Makowski M, Albert J, Cross K, Edara VV, Floyd K, Suthar MS, Martinez DR, Baric R, Buchanan W, Luke CJ, Phadke VK, Rostad CA, Ledgerwood JE, Graham BS, Beigel JH, mRNA-1273 Study Group.. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults. N Engl J Med 2020.
  • Clinical Epidemiology and Outcomes of Pediatric Musculoskeletal Infections.Yi J, Wood JB, Creech CB, Williams D, Jimenez-Truque N, Yildirim I, Sederdahl B, Daugherty M, Hussaini L, Munye M, Tomashek KM, Focht C, Watson N, Anderson EJ, Thomsen I. Clinical Epidemiology and Outcomes of Pediatric Musculoskeletal Infections. The Journal Of Pediatrics 2021, 234: 236-244.e2. PMID: 33771580, PMCID: PMC8238832, DOI: 10.1016/j.jpeds.2021.03.028.
  • Fast Development of High-Quality Vaccines in a Pandemic.Pischel L, Yildirim I, Omer SB. Fast Development of High-Quality Vaccines in a Pandemic. Chest 2021, 160: e1-e3. PMID: 33848535, PMCID: PMC8102080, DOI: 10.1016/j.chest.2021.03.063.
  • Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project.Garcia Quesada M, Yang Y, Bennett JC, Hayford K, Zeger SL, Feikin DR, Peterson ME, Cohen AL, Almeida SCG, Ampofo K, Ang M, Bar-Zeev N, Bruce MG, Camilli R, Chanto Chacón G, Ciruela P, Cohen C, Corcoran M, Dagan R, De Wals P, Desmet S, Diawara I, Gierke R, Guevara M, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kleynhans J, Kristinsson KG, Ladhani SN, McGeer A, Mwenda JM, Nuorti JP, Oishi K, Ricketson LJ, Sanz JC, Savrasova L, Setchanova LP, Smith A, Valentiner-Branth P, Valenzuela MT, van der Linden M, van Sorge NM, Varon E, Winje BA, Yildirim I, Zintgraff J, Knoll MD, The Pserenade Team. Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project. Microorganisms 2021, 9 PMID: 33916227, PMCID: PMC8066874, DOI: 10.3390/microorganisms9040738.
  • Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project.Deloria Knoll M, Bennett JC, Garcia Quesada M, Kagucia EW, Peterson ME, Feikin DR, Cohen AL, Hetrich MK, Yang Y, Sinkevitch JN, Ampofo K, Aukes L, Bacci S, Bigogo G, Brandileone MC, Bruce MG, Camilli R, Castilla J, Chan G, Chanto Chacón G, Ciruela P, Cook H, Corcoran M, Dagan R, Danis K, de Miguel S, De Wals P, Desmet S, Galloway Y, Georgakopoulou T, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kellner JD, Kleynhans J, Knol MJ, Kozakova J, Kristinsson KG, Ladhani SN, Lara CS, León ME, Lepp T, Mackenzie GA, Mad'arová L, McGeer A, Mungun T, Mwenda JM, Nuorti JP, Nzoyikorera N, Oishi K, De Oliveira LH, Paragi M, Pilishvili T, Puentes R, Rafai E, Saha SK, Savrasova L, Savulescu C, Scott JA, Scott KJ, Serhan F, Setchanova LP, Sinkovec Zorko N, Skoczyńska A, Swarthout TD, Valentiner-Branth P, van der Linden M, Vestrheim DF, von Gottberg A, Yildirim I, Hayford K, The Pserenade Team. Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project. Microorganisms 2021, 9 PMID: 33918127, PMCID: PMC8066045, DOI: 10.3390/microorganisms9040742.
  • Effect of Concomitant Antibiotic and Vaccine Administration on Serologic Responses to Rotavirus Vaccine.Anderson EJ, Lopman B, Yi J, Libster R, Creech CB, El-Khorazaty J, Baqar S, Yildirim I, Kao C, Rouphael N, Shane AL, Edwards K. Effect of Concomitant Antibiotic and Vaccine Administration on Serologic Responses to Rotavirus Vaccine. Journal Of The Pediatric Infectious Diseases Society 2020, 9: 479-482. PMID: 31237948, PMCID: PMC7495907, DOI: 10.1093/jpids/piz044.
  • Cryptosporidiosis among solid organ transplant recipient attendees at a summer camp.McAteer J, Jernigan S, Mao C, Gonzalez MD, Watson RJ, Liverman R, Tobin-D Angelo M, Dishman M H, Shane A, Yildirim I. Cryptosporidiosis among solid organ transplant recipient attendees at a summer camp. Pediatric Transplantation 2020, 24: e13649. PMID: 31885132, DOI: 10.1111/petr.13649.
  • Who is at risk of 13-valent conjugated pneumococcal vaccine failure?Yildirim M, Keskinocak P, Pelton S, Pickering L, Yildirim I. Who is at risk of 13-valent conjugated pneumococcal vaccine failure? Vaccine 2020, 38: 1671-1677. PMID: 31974018, DOI: 10.1016/j.vaccine.2019.12.060.
  • Urinary Tract Infections With Extended-spectrum-β-lactamase-producing Bacteria: Case-control Study.Amin O, Prestel C, Gonzalez MD, Lyon T, Shane A, Jaggi P, Tippett A, Yildirim I. Urinary Tract Infections With Extended-spectrum-β-lactamase-producing Bacteria: Case-control Study. The Pediatric Infectious Disease Journal 2020, 39: 211-216. PMID: 32032306, DOI: 10.1097/INF.0000000000002531.
  • Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine.Anderson EJ, Lai L, Wrammert J, Kabbani S, Xu Y, Priyamvada L, Hill H, Goll JB, Jensen TL, Kao C, Yildirim I, Rouphael N, Jackson L, Mulligan MJ. Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine. Vaccines 2020, 8 PMID: 32041104, PMCID: PMC7158692, DOI: 10.3390/vaccines8010069.
  • The VACCINES Act: Deciphering Vaccine Hesitancy in the Time of COVID-19.McAteer J, Yildirim I, Chahroudi A. The VACCINES Act: Deciphering Vaccine Hesitancy in the Time of COVID-19. Clinical Infectious Diseases : An Official Publication Of The Infectious Diseases Society Of America 2020, 71: 703-705. PMID: 32282038, PMCID: PMC7184475, DOI: 10.1093/cid/ciaa433.
  • Severe Pediatric COVID-19 Presenting With Respiratory Failure and Severe Thrombocytopenia.Patel PA, Chandrakasan S, Mickells GE, Yildirim I, Kao CM, Bennett CM. Severe Pediatric COVID-19 Presenting With Respiratory Failure and Severe Thrombocytopenia. Pediatrics 2020, 146 PMID: 32366611, PMCID: PMC7329259, DOI: 10.1542/peds.2020-1437.
  • Characteristics of Serotype 3 Invasive Pneumococcal Disease before and after Universal Childhood Immunization with PCV13 in Massachusetts.Lapidot R, Shea KM, Yildirim I, Cabral HJ, Pelton SI, Department Of Public Health TM. Characteristics of Serotype 3 Invasive Pneumococcal Disease before and after Universal Childhood Immunization with PCV13 in Massachusetts. Pathogens (Basel, Switzerland) 2020, 9 PMID: 32455770, PMCID: PMC7281000, DOI: 10.3390/pathogens9050396.
  • Influenza vaccine effectiveness and disease burden in children and adolescents with sickle cell disease: 2012-2017.Kao CM, Lai K, McAteer JM, Elmontser M, Quincer EM, Yee MEM, Tippet A, Jerris RC, Lane PA, Anderson EJ, Bakshi N, Yildirim I. Influenza vaccine effectiveness and disease burden in children and adolescents with sickle cell disease: 2012-2017. Pediatric Blood & Cancer 2020, 67: e28358. PMID: 32469138, PMCID: PMC8221251, DOI: 10.1002/pbc.28358.
  • Brincidofovir for the treatment of human adenovirus infection in pediatric solid organ transplant recipients: A case series.Londeree J, Winterberg PD, Garro R, George RP, Shin S, Liverman R, Serluco A, Romero R, Yildirim I. Brincidofovir for the treatment of human adenovirus infection in pediatric solid organ transplant recipients: A case series. Pediatric Transplantation 2020, 24: e13769. PMID: 32558134, DOI: 10.1111/petr.13769.
  • Initial posaconazole dosing to achieve therapeutic serum posaconazole concentrations among children, adolescents, and young adults receiving delayed-release tablet and intravenous posaconazole.Bernardo V, Miles A, Fernandez AJ, Liverman R, Tippett A, Yildirim I. Initial posaconazole dosing to achieve therapeutic serum posaconazole concentrations among children, adolescents, and young adults receiving delayed-release tablet and intravenous posaconazole. Pediatric Transplantation 2020, 24: e13777. PMID: 32639095, DOI: 10.1111/petr.13777.
  • Microbiology and radiographic features of osteomyelitis in children and adolescents with sickle cell disease.Kao CM, Yee ME, Maillis A, Lai K, Bakshi N, Rostad BS, Jerris RC, Lane PA, Yildirim I. Microbiology and radiographic features of osteomyelitis in children and adolescents with sickle cell disease. Pediatric Blood & Cancer 2020, 67: e28517. PMID: 32710705, PMCID: PMC8369475, DOI: 10.1002/pbc.28517.
  • Severe COVID-19 disease in two pediatric oncology patients.Stokes CL, Patel PA, Sabnis HS, Mitchell SG, Yildirim IB, Pauly MG. Severe COVID-19 disease in two pediatric oncology patients. Pediatric Blood & Cancer 2020, 67: e28432. PMID: 32779861, PMCID: PMC7361273, DOI: 10.1002/pbc.28432.
  • Herd Immunity and Implications for SARS-CoV-2 Control.Omer SB, Yildirim I, Forman HP. Herd Immunity and Implications for SARS-CoV-2 Control. JAMA 2020, 324: 2095-2096. PMID: 33074293, DOI: 10.1001/jama.2020.20892.
  • Recognition and Outcomes of Pneumococcal Meningitis in 2 Tertiary Pediatric Hospitals Since the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine.Stevens JP, Lively A, Jerris R, Yildirim I, Lantis P. Recognition and Outcomes of Pneumococcal Meningitis in 2 Tertiary Pediatric Hospitals Since the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine. Pediatric Emergency Care 2022, 38: e354-e359. PMID: 33181795, DOI: 10.1097/PEC.0000000000002288.
  • Differences in maternal group B Streptococcus screening rates in Latin American countries.HogenEsch E, De Mucio B, Haddad LB, Vilajeliu A, Ropero AM, Yildirim I, Omer SB. Differences in maternal group B Streptococcus screening rates in Latin American countries. Vaccine 2021, 39 Suppl 2: B3-B11. PMID: 33308886, DOI: 10.1016/j.vaccine.2020.10.082.
  • Assessment and Validation of Syndromic Case Definitions for Respiratory Syncytial Virus Testing in a Low Resource Population.Omer SB, Bednarczyk R, Kazi M, Guterman LB, Aziz F, Allen KE, Yildirim I, Ali SA. Assessment and Validation of Syndromic Case Definitions for Respiratory Syncytial Virus Testing in a Low Resource Population. The Pediatric Infectious Disease Journal 2019, 38: e57-e59. PMID: 30074977, PMCID: PMC6437080, DOI: 10.1097/INF.0000000000002159.
  • Further Evidence of MMR Vaccine Safety: Scientific and Communications Considerations.Omer SB, Yildirim I. Further Evidence of MMR Vaccine Safety: Scientific and Communications Considerations. Annals Of Internal Medicine 2019, 170: 567-568. PMID: 30831577, DOI: 10.7326/M19-0596.
  • Assessment and Validation of Syndromic Case Definitions for Respiratory Syncytial Virus Infections in Young Infants: A Latent Class Analysis.Lalani K, Yildirim I, Phadke VK, Bednarczyk RA, Omer SB. Assessment and Validation of Syndromic Case Definitions for Respiratory Syncytial Virus Infections in Young Infants: A Latent Class Analysis. The Pediatric Infectious Disease Journal 2019, 38: 1177-1182. PMID: 31568250, DOI: 10.1097/INF.0000000000002468.
  • Infants at Risk for Invasive Pneumococcal Disease in the 13-Valent Pneumococcal Conjugate Vaccine Era.Yildirim I, Pelton SI. Infants at Risk for Invasive Pneumococcal Disease in the 13-Valent Pneumococcal Conjugate Vaccine Era. Clinical Infectious Diseases : An Official Publication Of The Infectious Diseases Society Of America 2019, 69: 91-92. PMID: 30281070, DOI: 10.1093/cid/ciy848.
  • Impact of Pharmacy-Initiated Interventions on Influenza Vaccination Rates in Pediatric Solid Organ Transplant Recipients.Gattis S, Yildirim I, Shane AL, Serluco S, McCracken C, Liverman R. Impact of Pharmacy-Initiated Interventions on Influenza Vaccination Rates in Pediatric Solid Organ Transplant Recipients. Journal Of The Pediatric Infectious Diseases Society 2019, 8: 525-530. PMID: 30307524, DOI: 10.1093/jpids/piy095.
  • Incidence of invasive Haemophilus influenzae infections in children with sickle cell disease.Yee ME, Bakshi N, Graciaa SH, Lane PA, Jerris RC, Wang YF, Yildirim I. Incidence of invasive Haemophilus influenzae infections in children with sickle cell disease. Pediatric Blood & Cancer 2019, 66: e27642. PMID: 30724001, PMCID: PMC6472970, DOI: 10.1002/pbc.27642.
  • Hospitalization Is an Underutilized Opportunity to Vaccinate for Influenza.Anderson EJ, Kao C, Yildirim I. Hospitalization Is an Underutilized Opportunity to Vaccinate for Influenza. Mayo Clinic Proceedings 2019, 94: 377-379. PMID: 30832785, DOI: 10.1016/j.mayocp.2019.01.012.
  • Sirolimus-associated pericardial effusion with cardiac tamponade and interstitial pneumonitis in a hematopoietic stem cell transplant recipient.Joo SJ, Yildirim I, Stenger EO, Anderson EJ. Sirolimus-associated pericardial effusion with cardiac tamponade and interstitial pneumonitis in a hematopoietic stem cell transplant recipient. Pediatric Transplantation 2019, 23: e13425. PMID: 31012209, DOI: 10.1111/petr.13425.
  • Chest Wall Swelling in a Child With Pneumonia.McAteer J, Wang LA, Chan A, Raabe VN, Kamat P, Freeman A, Yildirim I. Chest Wall Swelling in a Child With Pneumonia. Clinical Pediatrics 2019, 58: 1462-1465. PMID: 31165640, DOI: 10.1177/0009922819853004.
  • Invasive Pneumococcal Disease-Not Evenly Shared by All Children.Pelton SI, Lapidot R, Yildirim I. Invasive Pneumococcal Disease-Not Evenly Shared by All Children. JAMA Pediatrics 2019, 173: 1023-1024. PMID: 31566674, DOI: 10.1001/jamapediatrics.2019.3185.
  • The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis.Balsells E, Dagan R, Yildirim I, Gounder PP, Steens A, Muñoz-Almagro C, Mameli C, Kandasamy R, Givon Lavi N, Daprai L, van der Ende A, Trzciński K, Nzenze SA, Meiring S, Foster D, Bulkow LR, Rudolph K, Valero-Rello A, Ducker S, Vestrheim DF, von Gottberg A, Pelton SI, Zuccotti G, Pollard AJ, Sanders EAM, Campbell H, Madhi SA, Nair H, Kyaw MH. The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis. The Journal Of Infection 2018, 77: 368-378. PMID: 29964140, DOI: 10.1016/j.jinf.2018.06.004.
  • Necrotizing fasciitis caused by Mucor indicus in a pediatric bone marrow transplant recipient.Bloch D, Gonzalez MD, Haight A, Abramowsky C, Yildirim I. Necrotizing fasciitis caused by Mucor indicus in a pediatric bone marrow transplant recipient. Pediatric Transplantation 2018, 22: e13294. PMID: 30246483, PMCID: PMC6460914, DOI: 10.1111/petr.13294.
  • Rapid Initiation of Antiretrovirals in Two Newly Diagnosed HIV-infected Infants.Clarke DF, Yildirim I, Cooper ER. Rapid Initiation of Antiretrovirals in Two Newly Diagnosed HIV-infected Infants. The Pediatric Infectious Disease Journal 2017, 36: 61-62. PMID: 27749654, DOI: 10.1097/INF.0000000000001353.
  • A fully liquid DTaP-IPV-HB-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Turkish infants and toddlersCeyhan M, Yıldırım İ, Tezer H, Devrim İ, Feroldi E. A fully liquid DTaP-IPV-HB-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Turkish infants and toddlers Turkish Journal Of Medical Sciences 2017, 47: 1247-1256. PMID: 29156870, DOI: 10.3906/sag-1609-62.
  • Surveillance of pneumococcal colonization and invasive pneumococcal disease reveals shift in prevalent carriage serotypes in Massachusetts' children to relatively low invasiveness.Yildirim I, Little BA, Finkelstein J, Lee G, Hanage WP, Shea K, Pelton SI. Surveillance of pneumococcal colonization and invasive pneumococcal disease reveals shift in prevalent carriage serotypes in Massachusetts' children to relatively low invasiveness. Vaccine 2017, 35: 4002-4009. PMID: 28645717, DOI: 10.1016/j.vaccine.2017.05.077.
  • Editorial Commentary: Influenza Vaccine Effectiveness: A Glass Both Half Full and Half Empty.Omer SB, Yildirim I. Editorial Commentary: Influenza Vaccine Effectiveness: A Glass Both Half Full and Half Empty. Clinical Infectious Diseases : An Official Publication Of The Infectious Diseases Society Of America 2016, 63: 1574-1576. PMID: 27702767, DOI: 10.1093/cid/ciw637.
  • Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease.Yildirim I, Shea KM, Little BA, Silverio AL, Pelton SI. Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease. Pediatrics 2015, 135: 495-503. PMID: 25647674, DOI: 10.1542/peds.2014-2426.
  • Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine.Yildirim I, Shea KM, Pelton SI. Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine. Infectious Disease Clinics Of North America 2015, 29: 679-97. PMID: 26610421, PMCID: PMC4662776, DOI: 10.1016/j.idc.2015.07.009.
  • Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods.Yildirim I, Stevenson A, Hsu KK, Pelton SI. Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods. The Pediatric Infectious Disease Journal 2012, 31: 1016-21. PMID: 22673142, DOI: 10.1097/INF.0b013e3182615615.
  • A case report of thrombocytopenia-associated multiple organ failure secondary to Salmonella enterica serotype Typhi infection in a pediatric patient: successful treatment with plasma exchange.Yildirim I, Ceyhan M, Bayrakci B, Uysal M, Kuskonmaz B, Ozaltin F. A case report of thrombocytopenia-associated multiple organ failure secondary to Salmonella enterica serotype Typhi infection in a pediatric patient: successful treatment with plasma exchange. Therapeutic Apheresis And Dialysis : Official Peer-reviewed Journal Of The International Society For Apheresis, The Japanese Society For Apheresis, The Japanese Society For Dialysis Therapy 2010, 14: 226-9. PMID: 20438547, DOI: 10.1111/j.1744-9987.2009.00714.x.
  • Risks and outcome of fungal infection in neutropenic children with hematologic diseases.Aytaç S, Yildirim I, Ceyhan M, Cetin M, Tuncer M, Kara A, Cengiz AB, Seçmeer G, Yetgin S. Risks and outcome of fungal infection in neutropenic children with hematologic diseases. The Turkish Journal Of Pediatrics 2010, 52: 121-5. PMID: 20560245.
  • Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease.Yildirim I, Hanage WP, Lipsitch M, Shea KM, Stevenson A, Finkelstein J, Huang SS, Lee GM, Kleinman K, Pelton SI. Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine 2010, 29: 283-8. PMID: 21029807, PMCID: PMC3139683, DOI: 10.1016/j.vaccine.2010.10.032.
  • Serosurveillance study on transmission of H5N1 virus during a 2006 avian influenza epidemic.Ceyhan M, Yildirim I, Ferraris O, Bouscambert-Duchamp M, Frobert E, Uyar N, Tezer H, Oner AF, Buzgan T, Torunoglu MA, Ozkan B, Yilmaz R, Kurtoglu MG, Laleli Y, Badur S, Lina B. Serosurveillance study on transmission of H5N1 virus during a 2006 avian influenza epidemic. Epidemiology And Infection 2010, 138: 1274-80. PMID: 20092669, DOI: 10.1017/S095026880999166X.
  • Secondary attack rate of hepatitis A, varicella and mumps in household settings and reliability of family history to detect seronegative children for necessity of vaccination.Ceyhan M, Tezer H, Yildirim I. Secondary attack rate of hepatitis A, varicella and mumps in household settings and reliability of family history to detect seronegative children for necessity of vaccination. Scandinavian Journal Of Infectious Diseases 2009, 41: 501-6. PMID: 19449259, DOI: 10.1080/00365540902968027.
  • Multicenter prospective study on the burden of rotavirus gastroenteritis in Turkey, 2005-2006: a hospital-based study.Ceyhan M, Alhan E, Salman N, Kurugol Z, Yildirim I, Celik U, Keser M, Koturoglu G, Tezer H, Bulbul EK, Karabocuoglu M, Halicioglu O, Anis S, Pawinski R. Multicenter prospective study on the burden of rotavirus gastroenteritis in Turkey, 2005-2006: a hospital-based study. The Journal Of Infectious Diseases 2009, 200 Suppl 1: S234-8. PMID: 19817603, DOI: 10.1086/605056.
  • Comparison of nasopharyngeal culture, polymerase chain reaction (PCR) and serological test for diagnosis of pertussis.Cengiz AB, Yildirim I, Ceyhan M, Seçmeer G, Gür D, Kara A. Comparison of nasopharyngeal culture, polymerase chain reaction (PCR) and serological test for diagnosis of pertussis. The Turkish Journal Of Pediatrics 2009, 51: 309-16. PMID: 19950836.
  • Frequency of pertussis in children with prolongued cough.Yildirim I, Ceyhan M, Kalayci O, Cengiz AB, Secmeer G, Gur D, Pelton S. Frequency of pertussis in children with prolongued cough. Scandinavian Journal Of Infectious Diseases 2008, 40: 314-9. PMID: 17934983, DOI: 10.1080/00365540701689659.
  • Linezolid-induced reversible bicytopenia in a 4-year-old boy with methicillin-resistant Staphylococcus aureus bacteremia.Tavil B, Balci YI, Yildirim I, Tavil Y, Secmeer G, Ceyhan M, Tuncer M. Linezolid-induced reversible bicytopenia in a 4-year-old boy with methicillin-resistant Staphylococcus aureus bacteremia. Pediatric Hematology And Oncology 2008, 25: 67-71. PMID: 18231956, DOI: 10.1080/08880010701703628.
  • A prospective comparative study of the relationship between different types of ring and microbial hand colonization among pediatric intensive care unit nurses.Yildirim I, Ceyhan M, Cengiz AB, Bagdat A, Barin C, Kutluk T, Gur D. A prospective comparative study of the relationship between different types of ring and microbial hand colonization among pediatric intensive care unit nurses. International Journal Of Nursing Studies 2008, 45: 1572-6. PMID: 18479684, DOI: 10.1016/j.ijnurstu.2008.02.010.
  • A prospective study of etiology of childhood acute bacterial meningitis, Turkey.Ceyhan M, Yildirim I, Balmer P, Borrow R, Dikici B, Turgut M, Kurt N, Aydogan A, Ecevit C, Anlar Y, Gulumser O, Tanir G, Salman N, Gurler N, Hatipoglu N, Hacimustafaoglu M, Celebi S, Coskun Y, Alhan E, Celik U, Camcioglu Y, Secmeer G, Gur D, Gray S. A prospective study of etiology of childhood acute bacterial meningitis, Turkey. Emerging Infectious Diseases 2008, 14: 1089-96. PMID: 18598630, PMCID: PMC2600347, DOI: 10.3201/eid1407.070938.
  • Comparison of the effect of benzathine penicillin G, clarithromycin, cefprozil and amoxicillin/clavulanate on the bacteriological response and throat flora in group A beta hemolytic streptococcal tonsillopharyngitis.Yildirim I, Ceyhan M, Gür D, Kaymakoğlu I. Comparison of the effect of benzathine penicillin G, clarithromycin, cefprozil and amoxicillin/clavulanate on the bacteriological response and throat flora in group A beta hemolytic streptococcal tonsillopharyngitis. The Turkish Journal Of Pediatrics 2008, 50: 120-5. PMID: 18664074.
  • A Chryseobacterium meningosepticum outbreak observed in 3 clusters involving both neonatal and non-neonatal pediatric patients.Ceyhan M, Yildirim I, Tekeli A, Yurdakok M, Us E, Altun B, Kutluk T, Cengiz AB, Gurbuz V, Barin C, Bagdat A, Cetinkaya D, Gur D, Tuncel O. A Chryseobacterium meningosepticum outbreak observed in 3 clusters involving both neonatal and non-neonatal pediatric patients. American Journal Of Infection Control 2008, 36: 453-7. PMID: 18675153, DOI: 10.1016/j.ajic.2007.09.008.
  • Cytomegalovirus hepatitis and ganciclovir treatment in immunocompetent children.Tezer H, Seçmeer G, Kara A, Ceyhan M, Cengiz AB, Devrim I, Us D, Yüce A, Gürakan F, Yildirim I, Ozen H, Saltik-Temizel IN. Cytomegalovirus hepatitis and ganciclovir treatment in immunocompetent children. The Turkish Journal Of Pediatrics 2008, 50: 228-34. PMID: 18773667.
  • Comparing body temperature measurements by mothers and physicians using mercury-in-glass, digital mercury and infrared tympanic membrane thermometers in healthy newborn babies.Cultu O, Yildirim I, Ceyhan M, Korkmaz A, Yurdakök M, Karaağaoğlu E, Seçmeer G. Comparing body temperature measurements by mothers and physicians using mercury-in-glass, digital mercury and infrared tympanic membrane thermometers in healthy newborn babies. The Turkish Journal Of Pediatrics 2008, 50: 354-8. PMID: 19014049.
  • What's eating you? Cutaneous myiasis (Wohlfahrtia magnifica).Yildirim I, Ceyhan M, Cengiz AB, Saki CE, Ozer E, Beken S, Cilsal E. What's eating you? Cutaneous myiasis (Wohlfahrtia magnifica). Cutis 2008, 82: 396-8. PMID: 19181028.
  • Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.Yildirim I, Aytac S, Ceyhan M, Cetin M, Tuncer M, Cengiz AB, Secmeer G, Yetgin S. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies. Pediatric Hematology And Oncology 2008, 25: 291-9. PMID: 18484473, DOI: 10.1080/08880010802016847.
  • Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.Secmeer G, Devrim I, Kara A, Ceyhan M, Cengiz B, Kutluk T, Buyukpamukcu M, Yetgin S, Tuncer M, Uludag AK, Tezer H, Yildirim I. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia. Journal Of Pediatric Hematology/oncology 2007, 29: 107-11. PMID: 17279007, DOI: 10.1097/MPH.0b013e3180320b5b.
  • Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.Ceyhan M, Yildirim I, Balmer P, Riley C, Laher G, Andrews N, Borrow R, Kurt N, Turgut M, Aydogan A, Ecevit C, Uysal G, Schultze V. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005. Vaccine 2007, 25: 7233-7. PMID: 17707957, DOI: 10.1016/j.vaccine.2007.07.019.
  • Isolated testicular and bone relapse in children with acute myeloblastic leukemia and chronic graft versus host disease after allogeneic BMT.Yildirim I, Uçkan D, Cetin M, Tuncer M, Tezcan I. Isolated testicular and bone relapse in children with acute myeloblastic leukemia and chronic graft versus host disease after allogeneic BMT. The Turkish Journal Of Pediatrics 2007, 49: 206-9. PMID: 17907524.
  • Accentuated varicella exanthems due to cast application.Kara A, Kurtul T, Ilke N, Yildirim I, Devrim I, Cengiz AB, Tezer H, Seçmeer G. Accentuated varicella exanthems due to cast application. Pediatric Dermatology 2007, 24: 558-60. PMID: 17958813, DOI: 10.1111/j.1525-1470.2007.00521.x.
  • Measurement accuracy of fever by tympanic and axillary thermometry.Devrim I, Kara A, Ceyhan M, Tezer H, Uludağ AK, Cengiz AB, Yiğitkanl I, Seçmeer G. Measurement accuracy of fever by tympanic and axillary thermometry. Pediatric Emergency Care 2007, 23: 16-9. PMID: 17228215, DOI: 10.1097/PEC.0b013e31802c61e6.
  • Life-threatening neurological complications after bone marrow transplantation in children.Uckan D, Cetin M, Yigitkanli I, Tezcan I, Tuncer M, Karasimav D, Oguz KK, Topçu M. Life-threatening neurological complications after bone marrow transplantation in children. Bone Marrow Transplantation 2005, 35: 71-6. PMID: 15531898, DOI: 10.1038/sj.bmt.1704749.
  • A new case of omphalocele with absence of thumb.Balci S, Leblebicioğlu G, Yiğitkanli I. A new case of omphalocele with absence of thumb. The Turkish Journal Of Pediatrics 2005, 47: 95-7. PMID: 15884640.
  • Complex facio-audio-symphalangism syndrome. An autosomal recessive type?Balci S, Yigitkanli I. Complex facio-audio-symphalangism syndrome. An autosomal recessive type? Genetic Counseling (Geneva, Switzerland) 2004, 15: 463-8. PMID: 15658623.
  • Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients.Arrieta AC, Neely M, Day JC, Rheingold SR, Sue PK, Muller WJ, Danziger-Isakov LA, Chu J, Yildirim I, McComsey GA, Frangoul HA, Chen TK, Statler VA, Steinbach WJ, Yin DE, Hamed K, Jones ME, Lademacher C, Desai A, Micklus K, Phillips DL, Kovanda LL, Walsh TJ. Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients. Antimicrobial Agents And Chemotherapy 2021, 65: e0029021. PMID: 34031051, PMCID: PMC8284446, DOI: 10.1128/AAC.00290-21.
  • Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19.Lucas C, Klein J, Sundaram ME, Liu F, Wong P, Silva J, Mao T, Oh JE, Mohanty S, Huang J, Tokuyama M, Lu P, Venkataraman A, Park A, Israelow B, Vogels CBF, Muenker MC, Chang CH, Casanovas-Massana A, Moore AJ, Zell J, Fournier JB, Wyllie AL, Campbell M, Lee AI, Chun HJ, Grubaugh ND, Schulz WL, Farhadian S, Dela Cruz C, Ring AM, Shaw AC, Wisnewski AV, Yildirim I, Ko AI, Omer SB, Iwasaki A. Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19. Nature Medicine 2021, 27: 1309. PMID: 34145437, PMCID: PMC8212078, DOI: 10.1038/s41591-021-01416-4.
  • COVID-19 Vaccine Acceptance among Health Care Workers in the Kingdom of Saudi Arabia.Elharake JA, Galal B, Alqahtani SA, Kattan RF, Barry MA, Temsah MH, Malik AA, McFadden SM, Yildirim I, Khoshnood K, Omer SB, Memish ZA. COVID-19 Vaccine Acceptance among Health Care Workers in the Kingdom of Saudi Arabia. International Journal Of Infectious Diseases : IJID : Official Publication Of The International Society For Infectious Diseases 2021, 109: 286-293. PMID: 34242765, PMCID: PMC8260488, DOI: 10.1016/j.ijid.2021.07.004.
  • Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation.Fujimoto AB, Keskinocak P, Yildirim I. Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation. Vaccine 2021, 39: 5055-5063. PMID: 34274126, PMCID: PMC8233959, DOI: 10.1016/j.vaccine.2021.06.067.
  • COVID-19 Vaccine Uptake Among US Child Care Providers.Patel KM, Malik AA, Lee A, Klotz M, Humphries JE, Murray T, Wilkinson D, Shafiq M, Yildirim I, Elharake JA, Diaz R, Reyes C, Omer SB, Gilliam WS. COVID-19 Vaccine Uptake Among US Child Care Providers. Pediatrics 2021, 148 PMID: 34452977, DOI: 10.1542/peds.2021-053813.
  • Respiratory Syncytial Virus-Associated Mortality Among Young Infants in Karachi, Pakistan: A Prospective Postmortem Surveillance Study.Kazi AM, Aguolu OG, Mughis W, Ahsan N, Jamal S, Khan A, Qureshi HM, Yildirim I, Malik FA, Omer SB. Respiratory Syncytial Virus-Associated Mortality Among Young Infants in Karachi, Pakistan: A Prospective Postmortem Surveillance Study. Clinical Infectious Diseases : An Official Publication Of The Infectious Diseases Society Of America 2021, 73: S203-S209. PMID: 34472574, PMCID: PMC8411247, DOI: 10.1093/cid/ciab488.
  • Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income Countries.Watson G, Dodd C, Munoz FM, Eckert LO, Jones CE, Buttery JP, Yildirim IB, Kachikis A, Heath PT, Schlaudecker EP, Bond NH, Santarcangelo PL, Wilcox CR, Bellamy K, Elmontser M, Sienas L, Simon R, Khalil A, Townsend R, Sturkenboom M, Black S. Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income Countries. The Pediatric Infectious Disease Journal 2021, 40: 1127-1134. PMID: 34596623, DOI: 10.1097/INF.0000000000003261.
  • Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach.Kim D, Pekgün P, Yildirim İ, Keskinocak P. Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach. Vaccine 2021, 39: 6876-6882. PMID: 34688498, PMCID: PMC8520874, DOI: 10.1016/j.vaccine.2021.10.025.
  • Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.Pegu A, O'Connell SE, Schmidt SD, O'Dell S, Talana CA, Lai L, Albert J, Anderson E, Bennett H, Corbett KS, Flach B, Jackson L, Leav B, Ledgerwood JE, Luke CJ, Makowski M, Nason MC, Roberts PC, Roederer M, Rebolledo PA, Rostad CA, Rouphael NG, Shi W, Wang L, Widge AT, Yang ES, Beigel JH, Graham BS, Mascola JR, Suthar MS, McDermott AB, Doria-Rose NA, Arega J, Beigel JH, Buchanan W, Elsafy M, Hoang B, Lampley R, Kolhekar A, Koo H, Luke C, Makhene M, Nayak S, Pikaart-Tautges R, Roberts PC, Russell J, Sindall E, Albert J, Kunwar P, Makowski M, Anderson EJ, Bechnak A, Bower M, Camacho-Gonzalez AF, Collins M, Drobeniuc A, Edara VV, Edupuganti S, Floyd K, Gibson T, Ackerley CMG, Johnson B, Kamidani S, Kao C, Kelley C, Lai L, Macenczak H, McCullough MP, Peters E, Phadke VK, Rebolledo PA, Rostad CA, Rouphael N, Scherer E, Sherman A, Stephens K, Suthar MS, Teherani M, Traenkner J, Winston J, Yildirim I, Barr L, Benoit J, Carste B, Choe J, Dunstan M, Erolin R, Ffitch J, Fields C, Jackson LA, Kiniry E, Lasicka S, Lee S, Nguyen M, Pimienta S, Suyehira J, Witte M, Bennett H, Altaras NE, Carfi A, Hurley M, Leav B, Pajon R, Sun W, Zaks T, Coler RN, Larsen SE, Neuzil KM, Lindesmith LC, Martinez DR, Munt J, Mallory M, Edwards C, Baric RS, Berkowitz NM, Boritz EA, Carlton K, Corbett KS, Costner P, Creanga A, Doria-Rose NA, Douek DC, Flach B, Gaudinski M, Gordon I, Graham BS, Holman L, Ledgerwood JE, Leung K, Lin BC, Louder MK, Mascola JR, McDermott AB, Morabito KM, Novik L, O'Connell S, O'Dell S, Padilla M, Pegu A, Schmidt SD, Shi W, Swanson PA, Talana CA, Wang L, Widge AT, Yang ES, Zhang Y, Chappell JD, Denison MR, Hughes T, Lu X, Pruijssers AJ, Stevens LJ, Posavad CM, Gale M, Menachery V, Shi PY. Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants. Science (New York, N.Y.) 2021, 373: 1372-1377. PMID: 34385356, PMCID: PMC8691522, DOI: 10.1126/science.abj4176.
  • Vaccination in pediatric solid organ transplant: A primer for the immunizing clinician.Chen JK, Cheng J, Liverman R, Serluco A, Corbo H, Yildirim I. Vaccination in pediatric solid organ transplant: A primer for the immunizing clinician. Clinical Transplantation 2022, 36: e14577. PMID: 34997642, DOI: 10.1111/ctr.14577.
  • Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination.Pérez-Then E, Lucas C, Monteiro VS, Miric M, Brache V, Cochon L, Vogels CBF, Malik AA, De la Cruz E, Jorge A, De Los Santos M, Leon P, Breban MI, Billig K, Yildirim I, Pearson C, Downing R, Gagnon E, Muyombwe A, Razeq J, Campbell M, Ko AI, Omer SB, Grubaugh ND, Vermund SH, Iwasaki A. Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination. Nature Medicine 2022, 28: 481-485. PMID: 35051990, PMCID: PMC8938264, DOI: 10.1038/s41591-022-01705-6.
  • Association of Child Masking With COVID-19-Related Closures in US Childcare Programs.Murray TS, Malik AA, Shafiq M, Lee A, Harris C, Klotz M, Humphries JE, Patel KM, Wilkinson D, Yildirim I, Elharake JA, Diaz R, Reyes C, Omer SB, Gilliam WS. Association of Child Masking With COVID-19-Related Closures in US Childcare Programs. JAMA Network Open 2022, 5: e2141227. PMID: 35084484, PMCID: PMC8796014, DOI: 10.1001/jamanetworkopen.2021.41227.
  • Lack of association between pandemic chilblains and SARS-CoV-2 infection.Gehlhausen JR, Little AJ, Ko CJ, Emmenegger M, Lucas C, Wong P, Klein J, Lu P, Mao T, Jaycox J, Wang E, Ugwu N, Muenker C, Mekael D, Klein RQ, Patrignelli R, Antaya R, McNiff J, Damsky W, Kamath K, Shon J, Ring AM, Yildirim I, Omer S, Ko AI, Aguzzi A, Iwasaki A. Lack of association between pandemic chilblains and SARS-CoV-2 infection. Proceedings Of The National Academy Of Sciences Of The United States Of America 2022, 119 PMID: 35217624, PMCID: PMC8892496, DOI: 10.1073/pnas.2122090119.
  • Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu.Petrone ME, Lucas C, Menasche B, Breban MI, Yildirim I, Campbell M, Omer SB, Ko AI, Grubaugh ND, Iwasak A, Wilen CB, Vogels CBF, Fauver JR. Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu. MedRxiv : The Preprint Server For Health Sciences 2022 PMID: 35378749, PMCID: PMC8978943, DOI: 10.1101/2022.03.28.22273077.
  • The balancing role of distribution speed against varying efficacy levels of COVID-19 vaccines under variants.Kim D, Keskinocak P, Pekgün P, Yildirim İ. The balancing role of distribution speed against varying efficacy levels of COVID-19 vaccines under variants. Scientific Reports 2022, 12: 7493. PMID: 35523832, PMCID: PMC9075929, DOI: 10.1038/s41598-022-11060-8.
  • No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination.Lu-Culligan A, Tabachnikova A, Pérez-Then E, Tokuyama M, Lee HJ, Lucas C, Silva Monteiro V, Miric M, Brache V, Cochon L, Muenker MC, Mohanty S, Huang J, Kang I, Dela Cruz C, Farhadian S, Campbell M, Yildirim I, Shaw AC, Ma S, Vermund SH, Ko AI, Omer SB, Iwasaki A. No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination. PLoS Biology 2022, 20: e3001506. PMID: 35609110, DOI: 10.1371/journal.pbio.3001506.
  • Relationship between the use of nonpharmaceutical interventions and COVID-19 vaccination among U.S. child care providers: A prospective cohort study.Patel KM, Shafiq M, Malik AA, Cobanoglu A, Klotz M, Eric Humphries J, Lee A, Murray T, Wilkinson D, Yildirim I, Elharake JA, Diaz R, Rojas R, Kuperwajs Cohen A, Omer SB, Gilliam WS. Relationship between the use of nonpharmaceutical interventions and COVID-19 vaccination among U.S. child care providers: A prospective cohort study. Vaccine 2022, 40: 4098-4104. PMID: 35660329, DOI: 10.1016/j.vaccine.2022.05.064.

Clinical Trials

ConditionsStudy Title
Diseases of the Lung; Diseases of the Respiratory SystemsA Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.
Diseases of the Respiratory Systems; COVID-19 Inpatient; COVID-19 OutpatientA Study Tracking Health Care Workers Exposed to COVID-19
Edit Profile